Avanir Pharmaceuticals to Announce Third Fiscal Quarter 2002 Results On August 13
Following the release, management will host a conference call with a simultaneous webcast at 1:30 p.m. Pacific/ 4:30 p.m. Eastern to discuss third fiscal quarter 2002 operating performance and outlook. The webcast will feature President and Chief Executive Officer Gerald J. Yakatan, Ph.D., Vice President and Chief Financial Officer Gregory Hanson and will be available live via the Internet by accessing Avanir's web site at www.avanir.com. Individual investors can also listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network such as America Online's Personal Finance Channel (available to AOL subscribers), Fidelity Investments(R) (Fidelity.com) and others. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com).
For those who cannot listen to the live broadcast, the online replays will be available for 90 days, or a phone replay will be available through August 20, 2002, by dialing 800-642-1687 or 706-645-9291 and entering the passcode 5210215.
Avanir Pharmaceuticals, based in San Diego, is a biopharmaceutical drug discovery and development company with an FDA-approved product. Avanir is engaged in research, discovery, development and licensing of innovative drug products and, through its subsidiary Xenerex Biosciences, antibody generation services.
Avanir Pharmaceuticals, San Diego
Investor Relations: Patrice Saxon, 858/622-5202
Kristen McNally, 310/407-6548
Analysts/Investors: Tricia Ross, 310/407-6540
Media: Tim Grace, 312/640-6667
Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page.
Copyright (C) 2002 Business Wire. All rights reserved.